Inspire Medical Systems (INSP) stock plunged 8.28% in after-hours trading on Monday, following the company's disclosure that it received a civil investigative demand from the U.S. Department of Justice regarding an investigation into potential violations of federal law.
The medical device company, which focuses on obstructive sleep apnea treatments, said it received the civil investigative demand on January 17. However, the nature and scope of the investigation were not disclosed.
While the impact of the DOJ probe remains unclear, such investigations often carry significant legal risks and costs for companies. Investors reacted negatively to the news, sending Inspire Medical's shares sharply lower in the extended trading session.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。